Clinical Trials Browser

Suspended × Carcinoma, Non-Small-Cell Lung × Panitumumab × Clear all

NCT01088620 2013-03-14

Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer

Phase 2 Suspended

Carcinoma, Non-Small-Cell Lung